We generated AAV(L):bPGRN (L = liver, b = brain-penetrant), a liver-targeting adenovirus (AAV) encoding a fusion protein (8D3:PGRN) consisting of a single chain fragment variable (scFv) antibody recognizing mouse TfR (transferrin receptor) fused to human PGRN (hPGRN). To study the effects of AAV(L):bPGRN, we treated 6-week old wildtype or GRN,TMEM106B double knock-out mice with either 1.3 x 10^13 vg/kg AAV or isotonic saline solution (0.9% NaCl) intravenously via tail vain injection. 9-10 weeks after the treatment the animals were sacrificed; they were anesthetized and transcardiacally perfused with PBS. From each animal, one hemibrain (excluding the olfactory bulb, but including cerebellum) was collected, snap frozen on dry ice and pulverized with a pistill. All animal experiments were performed according to German animal welfare law and approved by the government of upper Bavaria.
Creators
Not specifiedSubmitter
Views: 31
Created: 2nd Dec 2024 at 09:53
Last updated: 2nd Dec 2024 at 09:58
This item has not yet been tagged.
None
Version History
Version 1 (earliest) Created 2nd Dec 2024 at 09:53 by Aditi Methi
No revision comments